A Web-Based Application for Risk Stratification and Optimization in Patients With Cardiovascular Disease: Pilot Study.

ABSTRACT:

Background

In addition to aspirin, angiotensin-converting enzyme inhibitors, statins, and lifestyle modification interventions, novel pharmacological agents have been shown to reduce morbidity and mortality in atherosclerotic cardiovascular disease patients, including new antithrombotics, antihyperglycemics, and lipid-modulating therapies. Despite their benefits, the uptake of these guideline-directed therapies remains a challenge. There is a need to develop strategies to support knowledge translation for the uptake of secondary prevention therapies.

Objective

The goal of this study was to test the feasibility and usability of Stratification and Optimization in Patients With Cardiovascular Disease (STOP-CVD), a point-of-care application that was designed to facilitate knowle

SUBMITTER: Pandey A 

PROVIDER: S-EPMC10436122 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature